Lhermusier, Thibault
Ohayon, Paul
Boudou, Nicolas
Bouisset, Frederic
Campelo-Parada, Francisco
Roncalli, Jerome
Elbaz, Meyer
Carrié, Didier http://orcid.org/0000-0001-7557-1746
Funding for this research was provided by:
Boston Scientific Corporation (131350008008102651082)
Article History
Received: 8 February 2018
Accepted: 18 March 2019
First Online: 11 April 2019
Ethics approval and consent to participate
: Written informed consent was obtained from all the patients before the initiation of trial procedures. The study was conducted in compliance with Good Clinical Practice, French law and the French data protection law. The protocol was reviewed and approved by the Committee for the Protection of Human Subjects (CPP) Sud Ouest et Outre Mer n°1 (1–15-27) in january 2016. ClinicalTrials.gov Identifier: NCT02890589.
: The corresponding author obtained written permission from all individuals named in.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.